This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
This document shares essential recommendations to help pharma companies develop business forecasting, based on academic methods and...
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...